IMPC Industry Liaison Work Group
The laboratory mouse as a model of human disease has proved to be a powerful tool for drug development, with dozens of the top selling medicines generated in part through the application of a mouse model. We believe there is great opportunity for the IMPC to benefit the Biotech and Pharmaceutical industries by providing access to its pipeline of targeted mouse mutant strains and subsequent phenotyping information. The IMPC can add value to internal research and development programs, including pre-clinical target or pathway identification, validation and mechanistic studies. Likewise, the biotech and pharmaceutical industry have valuable perspectives on the the demands and needs for future drug development, and as such can help the IMPC shape its programs to bring added value to the medical community. To help facilitate these goals, we have set up an "Industry Liaison Working Group" tasked to reach out to and work with potential Industry partners.
The working group will establish an industry engagement plan to consider ways to reduce costs of IMPC through partnership, identify technologies that may advance the IMPC goals, and communicate with the wider industry community informing them about the activities of the IMPC. It will take into account the expert views, experiences and expectations of industry researchers working with mouse models or providing products, services, or enabling technology platforms.
Key elements of our engagement plan over the next few years will include:
- Create Value: Consider how the IMPC can best serve the needs of the biotechnology, pharmaceutical, and product and service industries.
- Facilitate Communication: Promote dialog with industry so that they are aware of the IMPC research program, encourage access and uptake of data, technology, analysis tools, and mouse models.
- Establish Collaboration: Gauge what interest BioPharma, Contract Research Organizations, and platform vendors have for participating in the IMPC. Consider developing IMPC - Industry partnerships.
- Encourage Contribution: Fashion opportunities for industry to contribute either funds or in kind resources such as services, reagents, information, or technology to advance the IMPC programs.
Members of Working Group
- Tom Weaver, Chair (Oxford, UK)
- Allan Bradley (Cambridge, UK)
- Martin Hrabe de Angelis (Munich, Germany)
- Colin McKerlie (Toronto, Canada)
- Mark Moore (San Francisco, USA)
For more information email@example.com